IDIBELL organized a meeting of breast cancer solidarity donors and associations
Yesterday, the breast cancer research team received associations and individuals who, thanks to their donations, have promoted research.
September 2022
The fourth edition of Sinergia arrives, the festival of health research and innovation of L’Hospitalet
Throughout the week of October 3rd to 8th, gymkhanas, talks, visits, and many other activities will bring science from the Bellvitge Campus closer to the public.
Success of the second symposium of the Oncobell research program
This Monday and Tuesday, September 19 and 20, the second Oncobell Symposium was held in the auditorium of the Bellvitge University Hospital. Under the slogan “building bridges between science, medicine and people” the congress is a forum to discuss the latest advances in basic and clinical research with top-level cancer professionals
IDIBELL researchers analyze the evidence of iron supplementation in chronic heart failure
They have shown that intravenous iron administration improves the quality of life and prognosis in patients with heart failure and ventricular dysfunction.
The IDIBELL-Ins Bellvitge Tandem opens the academic year with the inauguration of new scientific instruments for the secondary school laboratory
During the academic year that is beginning, the Tandem will continue educational projects that have been successful in recent years, such as the production of Life & Science magazine, the European Stars Game project, the Women of Science series, or the implementation of new laboratory practices in charge of the URIB
Access to quality medical and emotional information during breast cancer through digital platforms could reduce patient discomfort
Misinformation about the disease is one of the most stressful factors for patients. For this reason, creating quality content could help maintain emotional well-being.
A study with IDIBELL participation validates the effectiveness of biological treatments in severe asthma cases
The multicenter study in real life at the state level has been carried out with patients with severe asthma from a dozen hospitals and its main conclusion is that biological therapy is effective in both cases
The age at onset of multiple sclerosis has increased over the last decades
An IDIBELL and the Bellvitge University Hospital study has detected that the age at which the first symptoms appear has progressively increased from 1970 to 2019.
An IDIBELL study identifies the mechanisms by which NOX4 acts as a molecular brake on liver cancer
The work shows that in a NOX4 low activity situation, liver cancer cells reprogram the metabolism, causing oxidative stress, which favors tumor progression.